NCT04935463已完成不适用
Mucormycosis in COVID-19
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 728
- 试验地点
- 1
- 主要终点
- Vision loss
研究概览
简要总结
The purpose is to allow phsyician reporters to contribute to MUNCO registry. Mucormycosis in COVID-19 is a rapidly escalating medical emergency reported in high numbers in India during the ongoing coronavirus surge. There is very little known about the risk factors, patterns and complications of mucormycosis as it occurs either during the infection or treatment phase of the novel coronavirus (COVID-19). In light of this emerging epidemic within a pandemic, it is of time sensitive importance to obtain a better understanding of the risk factors and outcomes of this fatal complication
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosed case of Mycotic Infection in COVID-19
排除标准
- 未提供
结局指标
主要结局
Vision loss
时间窗: 60 days
次要结局
未报告次要终点
研究者
Shitij Arora
Associate Professor
Montefiore Medical Center
研究点 (1)
Loading locations...
相似试验
已完成
不适用
COVID-19 Associated Mucormycosis: A Multidisciplinary Dilemma in Assiut University HospitalMucormycosisNCT05074043Assiut University433
已完成
不适用
Post-COVID-19 Mucormycosis in Critical CareMucormycosis; Rhinocerebral (Etiology)Post COVID-19 Condition, UnspecifiedNCT05911035Zagazig University150
已完成
不适用
Registry of COVID-19 Patients at AOUI VeronaCoronavirus Disease 2019NCT04497194Azienda Ospedaliera Universitaria Integrata Verona430
终止
不适用
Serology to COVID-19 for Recording Exposures and Evaluating NeedsCovid19CoronavirusSARS-CoV InfectionNCT04566965Children's Hospital Medical Center, Cincinnati232
进行中(未招募)
不适用
COVID-19 BiorepositoryCovid-19SARS-CoV 2CoronavirusCOVIDNCT04568148University of Kansas Medical Center201
